Bacil Pharma Limited (BOM:524516)
50.03
-1.06 (-2.07%)
At close: May 29, 2026
20.41% (1Y)
| Market Cap | 718.08M +111.2% |
| Revenue (ttm) | n/a |
| Net Income | 7.38M +112.0% |
| EPS | 0.60 -1.9% |
| Shares Out | 14.35M |
| PE Ratio | 83.51 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,365 |
| Open | 52.11 |
| Previous Close | 51.09 |
| Day's Range | 49.00 - 52.11 |
| 52-Week Range | 26.69 - 61.80 |
| Beta | 0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 22, 2026 |